Collaboration across organizations, steady performance under pressure, and a drive toward a common goal — veterans like Birk Stathers bring an extraordinary foundation to FDA's work. This #VeteransDay, we're grateful for all who have served.
Ready to bring your skills to FDA? Explore opportunities: fda.gov/jobs
#FDAVeterans
1
2,413
Selfless service and a mission greater than yourself is not just a military value, it's the foundation of everything we do at FDA. We're honored to have veterans like Stacey Talley who carry that mindset into their work protecting public health every day. 🇺🇸
Your next mission awaits. Explore FDA careers: fda.gov/jobs
#FDAVeterans
Protecting the public health is a mission veterans understand. Darlise Henderson knew FDA was the right fit and we think other veterans will too. This #VeteransDay, we encourage all former service members to continue the charge and explore a career at FDA. fda.gov/jobs
#FDAVeterans
On #VeteransDay, we honor those who served — those who came home and those who did not. FDA is proud to have veterans like Brandon Finke among us, carrying that spirit of service into our public health mission every day. Thank you to all who have served. 🇺🇸
Ready to continue your service? Explore career opportunities at FDA: fda.gov/jobs
#FDAVeterans

ALT Sure, I can help with that. The image contains a banner with the FDA logo and the text "FDA Honors Those Who Served" at the top. Below is a photograph of a person in military uniform standing outside. There is a quote on the left side: "Veterans day is a day I reflect on those I served with and remember not only the ones that I returned with but also the ones who failed to return and the gratitude I have towards all of them." The quote is attributed to Brandon Finke.
On Veterans Day, the FDA proudly honors the men and women who have answered our nation's call to serve, in times of both peace and war. We recognize their service, sacrifice, and unwavering commitment to our country.
Today, Acting FDA Commissioner Kyle Diamantas spoke with @CancerResrch about FDA's role in the future of oncology research & development. We're committed to advancing safe, effective & innovative cancer treatments for patients.
Start watching at 9 min ⬇️
youtube.com/live/BtfhFNTaXes…
FDA has posted its FY27 BAA funding solicitations for extramural research supporting regulatory science & innovation! To learn more, join us for FDA BAA Industry Day on Dec. 8. Proposals are due by 5p ET, Jan. 22. Early applications are encouraged! fda.gov/science-research/adv…
4
6
5,006
This #VeteransDay, FDA's Oncology Center of Excellence & @VAResearch are teaming up with a new MOU. It supports collaboration on dose optimization, real-world evidence, & more — all to better serve #Veterans and protect public health. fda.gov/about-fda/oncology-c…
The first project under this MOU is already underway! Researchers are studying how variants in the DPYD gene affect the body's processing of the chemotherapy drug 5-fluorouracil (5-FU) in veterans with colorectal cancer.
Today, we are informing patients and health care providers of a potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with use of GLP-1 RA medications.
NAION is a rare condition that can result in acute, painless, decreased vision in one eye, including permanent vision loss. Symptoms of NAION include sudden, painless vision loss in one eye that patients may notice upon waking: visual defects such as blind spots, distortion of colors, blurriness, or tunnel vision.
Patients should contact their health care professional right away if they have any of these symptoms. fda.gov/drugs/drug-safety-co…
November is #DiabetesAwarenessMonth. Discover how 💉insulin #biosimilars can safely and effectively help treat health conditions such as diabetes: fda.gov/media/172979/downloa…
U.S. FDA retweeted
Today, FDA approved a treatment for adult patients with recurrent or metastatic head and neck squamous cell cancer whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.
This is an aggressive, life-threatening disease for which there is a high unmet need for effective therapies. fda.gov/news-events/press-an…
For the 95% of rare disease patients still without an approved treatment, FDA is working for you.
Acting Commissioner Kyle Diamantas shares how FDA is transforming rare disease drug development through the new Rare Disease Framework Initiative. Because every family deserves answers, action, and hope. fda.gov/news-events/fda-voic…
New infant formula data. Proposed nutrient updates. Our ongoing commitment to America’s babies.
FDA is sharing Operation Stork Speed testing results and proposing changes to some infant formula nutrient requirements.
Explore the data and weigh in on the proposal: fda.gov/food/infant-formula-…











